Home Alzheimer’s Disease Zsofia K. Stadler, MD, on the Importance of Germline Analyses in Advanced...

Zsofia K. Stadler, MD, on the Importance of Germline Analyses in Advanced Cancer

Germline analysis in patients with advanced cancer may play an important role in selecting FDA-approved treatments and clinical trial participation with germline-targeted therapeutics, according to a pan-cancer analysis presented at the 2020 ASCO Virtual Scientific Program.

In the analysis, 6.5% of patients (n = 11,975) who had germline genetic testing through a prospective protocol using MSK-IMPACT, a next-generation sequencing panel, harbored a targetable germline variant.

In a recent interview with CancerNetwork, Zsofia K. Stadler, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, spoke about the aim of the study, its results, and future studies that will be conducted.

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

please help us fundraise (501c3 non-profit) : braincancer

I work with OurBrainBank, a start-up non-profit dedicated to moving glioblastoma from terminal to treatable, powered by patients.We're a registered 501c3 non-profit in the...

Cancer and Mental Health Re-post : braincancer

Hello!I would like to thank everyone who participated in my survey these past few months! I received a tremendous response and I truly, truly...

Recent Comments